UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition AnafranilRet-75mg-Tablet-SE-IS-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100012657-00010568, http://ema.europa.eu/fhir/eurdId
/811
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Prolonged-release tablet
indication:
Egentlig depression med melankoli. Djupa eller långvariga egentliga depressioner utan melankoli. Paniksyndrom med eller utan agorafobi. Agorafobi. Tvångstillstånd. Associerade symtom vid narkolepsi (speciellt kataplexi, sömnparalys och hypnagoga hallucinationer). Idiopatiskt smärtsyndrom med depressiva symtom.
legalStatusOfSupply: Medicinal product subject to medical prescription
classification: N06AA04
name
productName: Anafranil® Retard 75 mg Depottablett
part
part: Anafranil® Retard
type: Invented name part
part
part: 75 mg
type: Strength part
part
part: Depottablett
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish
Type |
Depottablett |